Updates are available Correction dated 2025-02-04
Click to view Correction: https://doi.org/10.1007/s10456-024-09968-y
-
Authors
Pal, Sagnik
Su, Yangyang
Nwadozi, Emmanuel
Claesson-Welsh, Lena
Richards, Mark
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2022-00896)
Knut och Alice Wallenbergs Stiftelse (KAW 2020.0057)
Fondation Leducq (17 CVD 03)
Olle Engkvists Stiftelse (218-0057)
Svenska Sällskapet för Medicinsk Forskning (201912)
EMBO (ALTF 923-2016)
Uppsala University
- License Information
-
More Information
Article History
Received: 17 November 2024
Accepted: 1 December 2024
First Online: 12 December 2024
Change Date: 7 January 2025
Change Type: Update
Change Details: The original online version of this article was revised: Figure 2 is updated.
Change Date: 4 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10456-024-09968-y
Declarations
:
: M.R. is now an employee for AstraZeneca (Biopharmaceuticals R&D, Cambridge, UK). All of this work was performed at Dept. of Immunology, Genetics and Pathology, Beijer and Science for Life Laboratories, Uppsala University, Uppsala, Sweden. No funding or support was received from AstraZeneca. Other authors declared no conflict of interest.
